Raymond James & Associates Acquires 15,578 Shares of Innospec Inc. (NASDAQ:IOSP)

Raymond James & Associates grew its holdings in shares of Innospec Inc. (NASDAQ:IOSPGet Rating) by 35.7% in the first quarter, HoldingsChannel reports. The fund owned 59,220 shares of the specialty chemicals company’s stock after purchasing an additional 15,578 shares during the quarter. Raymond James & Associates’ holdings in Innospec were worth $5,481,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of IOSP. Victory Capital Management Inc. grew its position in shares of Innospec by 54.9% during the 1st quarter. Victory Capital Management Inc. now owns 804,981 shares of the specialty chemicals company’s stock valued at $74,530,000 after acquiring an additional 285,307 shares during the period. Champlain Investment Partners LLC grew its position in shares of Innospec by 18.0% during the 4th quarter. Champlain Investment Partners LLC now owns 988,195 shares of the specialty chemicals company’s stock valued at $89,274,000 after acquiring an additional 150,615 shares during the period. Leeward Investments LLC MA bought a new stake in shares of Innospec during the 1st quarter valued at $9,787,000. Telemark Asset Management LLC grew its position in shares of Innospec by 66.7% during the 4th quarter. Telemark Asset Management LLC now owns 250,000 shares of the specialty chemicals company’s stock valued at $22,585,000 after acquiring an additional 100,000 shares during the period. Finally, Wasatch Advisors Inc. boosted its holdings in Innospec by 15.3% in the 4th quarter. Wasatch Advisors Inc. now owns 642,200 shares of the specialty chemicals company’s stock worth $58,016,000 after buying an additional 85,102 shares during the period. Institutional investors own 96.42% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Monday, May 9th.

Innospec Stock Performance

Shares of Innospec stock opened at $89.37 on Monday. The company has a market capitalization of $2.22 billion, a P/E ratio of 19.22 and a beta of 1.14. The company has a fifty day moving average of $96.87 and a 200 day moving average of $96.59. Innospec Inc. has a fifty-two week low of $81.00 and a fifty-two week high of $106.87.

Innospec Company Profile

(Get Rating)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels.

See Also

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPGet Rating).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.